Colgate-Palmolive Company: Q3 2000 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for Colgate-Palmolive Company for the period ended September 30, 2000. The company operates globally in Oral, Personal, and Household Care, as well as Pet Nutrition. As of October 31, 2000, there were 572,236,615 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q3 2000 | Q3 1999 | 9M 2000 | 9M 1999 |
|---|---|---|---|---|
| Net Sales | $2,366.5M | $2,314.0M | $6,945.0M | $6,774.3M |
| Gross Profit | $1,293.5M | $1,253.6M | $3,785.6M | $3,640.8M |
| Gross Margin | 54.7% | 54.2% | 54.5% | 53.7% |
| Net Income | $275.3M | $239.7M | $777.1M | $676.7M |
| Diluted EPS | $0.44 | $0.38 | $1.24 | $1.06 |
| Operating Cash Flow (9M) | $1,081.8M (2000) vs $964.1M (1999) | |||
| Cash & Equivalents | $210.9M (Sep 30, 2000) | |||
| Total Debt (Current + Long-term) | $2,942.7M (Sep 30, 2000) |
Material Changes vs. Prior Period
- Revenue Growth: Q3 sales increased 2% year-over-year, driven by a 5% unit volume gain partially offset by foreign currency declines. Excluding currency effects, sales would have risen 7%.
- Profitability: Net income rose 15% in both Q3 and the first nine months. Gross margins improved due to manufacturing streamlining and global sourcing. SG&A expenses as a percentage of sales decreased to 36.0% from 36.8% in Q3 1999.
- Regional Performance:
- North America: Sales up 11% (Volume +10%) driven by new toothpaste and toothbrush products.
- Latin America: Sales up 5% (Volume +2%).
- Europe: Sales down 9% due to the weakened Euro, though volume grew 2%.
- Asia/Africa: Sales up 3% with strong volume growth of 9%.
- Debt Structure: Total debt increased, with interest expense rising to $48.3M in Q3 2000 from $43.8M in Q3 1999. However, $793.2M of commercial paper is classified as long-term debt due to refinancing intent.
Outlook, Risks, and Unusual Items
- Accounting Changes: The company will adopt EITF Issue No. 00-14 regarding sales incentives in Q4 2000, expected to impact revenue/expense classification but not net income. FAS 133 (Derivatives) adoption is effective Jan 1, 2001, with no material impact expected.
- Currency Impact: Significant foreign currency translation adjustments occurred, including a $15.7M charge in the first nine months due to the devaluation of the Brazilian Real.
- Capital Allocation: The company paid $704.0M for common stock repurchases and $283.3M in dividends during the first nine months of 2000.
- Legal Proceedings: Referenced in the 1999 10-K; no new material legal proceedings detailed in this filing.
Investor Verification Checklist
- Verify the sustainability of the 5% unit volume growth amidst foreign currency headwinds.
- Confirm the classification of $793.2M commercial paper as long-term debt and the company's refinancing capacity.
- Monitor the impact of the Euro's weakness on the Europe segment's reported revenue versus underlying volume.
- Review the adoption of EITF 00-14 in Q4 2000 for potential shifts in revenue recognition timing.
- Assess the effectiveness of cost reduction programs in maintaining SG&A at 36.0% of sales.